Optimizing Patient Outcomes in Gaucher Disease: Evaluating the Latest Enzyme Replacement Therapies

Optimizing Patient Outcomes in Gaucher Disease: Evaluating the Latest Enzyme Replacement Therapies is organized by Med Learning Group.,Release Date: May 26, 2022,Expiration Date: May 26, 2023,Program Overview:,This online activity is designed to increase HCPs' recognition of metabolic pathways involved in the pathophysiology of Gaucher disease; confidence in discussing clinical trial data supporting improved outcomes in Gaucher disease; understanding of the potential for treatment to modify outcomes in Gaucher disease, and understanding of shared decision-making best practices for long-term management of Gaucher disease.,Learning Objectives:,Upon the completion of this program, attendees should be able to:,• Recognize the metabolic pathways relevant to different lysosomal storage diseases including Gaucher disease’s relevant mechanisms of enzyme replacement therapy,• Summarize clinical data with specific therapies in the management of Gaucher disease,• Evaluate best practices for long-term management, assessment, and shared decision-making with patients and caregivers of patients with Gaucher disease